drugset / Trial / NCT00895713
Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to determine if treatment with intramuscular hepatitis B virus immune globulin Grifols, a new specific hepatitis B immune globulin, is effective and safe for the prevention of hepatitis B virus recurrence after orthotopic liver transplantation.
Timeline
- Start
- 2004-11
- Primary completion
- 2005-06
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hepatitis B virus immune globulin | Protein / enzyme biologic | 2000 iu | Intramuscular |